Yu-wen Zhou

37 Guoxue Xiang Street
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Vemurafenib, cetuximab and camrelizumab in BRAF V600E-mutated/MSS metastatic colorectal cancer.

Vemurafenib, cetuximab and camrelizumab in BRAF V600E-mutated/MSS metastatic colorectal cancer.

Journal: Journal of translational medicine
Published: July 31, 2025

Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial.

Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial.

Journal: ESMO open
Published: April 16, 2025

Catalyst-free Ullmann coupling in aqueous microdroplets.

Catalyst-free Ullmann coupling in aqueous microdroplets.

Journal: Nature communications
Published: April 02, 2025

Attitude changes of cancer pain and opioids among cancer patients: a cross-sectional study spanning a decade.

Attitude changes of cancer pain and opioids among cancer patients: a cross-sectional study spanning a decade.

Journal: BMC cancer
Published: November 13, 2024

Clinicopathologic features and treatment efficacy of patients with BRAF V600E-mutated metastatic colorectal cancer: a multi-center real-world propensity score matching study.

Clinicopathologic features and treatment efficacy of patients with BRAF V600E-mutated metastatic colorectal cancer: a multi-center real-world propensity score matching study.

Journal: BMC cancer
Published: June 20, 2024

Locoregional therapies combined with immune checkpoint inhibitors for liver metastases.

Locoregional therapies combined with immune checkpoint inhibitors for liver metastases.

Journal: Cancer cell international
Published: June 11, 2024

A nomogram construction and multicenter validation for predicting overall survival after fruquintinib application in patients with metastatic colorectal cancer: a multicenter retrospective study.

A nomogram construction and multicenter validation for predicting overall survival after fruquintinib application in patients with metastatic colorectal cancer: a multicenter retrospective study.

Journal: Therapeutic advances in gastroenterology
Published: March 28, 2024

Application of artificial intelligence in the diagnosis, treatment, and recurrence prediction of peritoneal carcinomatosis.

Application of artificial intelligence in the diagnosis, treatment, and recurrence prediction of peritoneal carcinomatosis.

Journal: Heliyon
Published: February 21, 2024

Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database.

Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database.

Journal: BMJ open
Published: December 15, 2023

Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.

Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.

Journal: International immunopharmacology
Published: September 20, 2023

Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC).

Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC).

Journal: Expert review of gastroenterology & hepatology
Published: September 14, 2023

Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions.

Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions.

Journal: Frontiers in immunology
Published: July 29, 2023
Showing 1-12 of 31

Last Updated: 09/26/2026